1. Laboratory
  2. Laboratory medicine
  3. Pregnancy test kit
  4. Chengdu Vacure Biotechnology Co., Ltd
  • Products
  • Catalogs
  • News & Trends
  • Exhibitions

Pregnancy test kit LYOFIA®
sFLt-1serumplasma

Pregnancy test kit - LYOFIA® - Chengdu Vacure Biotechnology Co., Ltd - sFLt-1 / serum / plasma
Pregnancy test kit - LYOFIA® - Chengdu Vacure Biotechnology Co., Ltd - sFLt-1 / serum / plasma
Pregnancy test kit - LYOFIA® - Chengdu Vacure Biotechnology Co., Ltd - sFLt-1 / serum / plasma - image - 2
Add to favorites
Compare this product
 

Characteristics

Applications
pregnancy
Tested parameter
sFLt-1
Sample type
serum, plasma, whole blood
Analysis mode
immunoassay, fluorescence
Format
cassette
Result display time

10 min

Description

This Fluorescent Immunoassay PLGF and sFLT-1 POCT Kit is designed for in vitro quantitative detection of PLGF and sFLT-1 in whole blood ,serum and plasma samples. It’s for professional only. Summary Soluble fms-like tyrosine kinase-1 (sFlt-1) is a truncated tyrosine kinase form that disables proteins with antiangiogenic properties and a shortened non-membrane splice variant of VEGFreceptor 1 (Flt-1) that signals angiogenesis. It contains an extracellular domain identical to that of Flt-1, but lacks both the transmembrane and intercellular domains present in Flt-1.Instead, sFlt-1 contains a novel 31 amino acid C-terminal sequence and 6 immunoglobulin- like domains, with a binding site for VEGF and PIGF within the second domain from the N-terminus,resulting that sFlt-1 competes with Flt-1 to bind VEGF and PIGF, which effectively reducing serum concentrations of these two angiogenic growth factors. PlGF is a protein highly expressed by the placenta with vasculogenic and angiogenic properties, which has a central role in spiral artery remodeling and the development of a low-resistance placental capillary network. Increased rates of preterm birth Low PIGF levels in high-risk pregnant women between 20° and 36 weeks of gestation is associated with increased risk of early-onset pre-eclampsia Increased risk of stillbirth characterized by severe placental vascular disease. Principle The fluorescent immunoassay PLGF and sFLT-1 POCT kit adopts microfluidic fluorescence immunoluminescence method, Why Test sFLT-1 and PLGF? Pre-eclampsia (PE) is a complex multisystem disease of pregnancy globally responsible fora significant burden of maternal,perinatal,
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.